Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Organon & Co. (OGN)

Organon & Co. (OGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,105,862
  • Shares Outstanding, K 259,983
  • Annual Sales, $ 6,216 M
  • Annual Income, $ 187,000 K
  • EBIT $ 1,125 M
  • EBITDA $ 1,402 M
  • 60-Month Beta 0.58
  • Price/Sales 0.31
  • Price/Cash Flow 1.64
  • Price/Book 2.16

Options Overview Details

View History
  • Implied Volatility 50.88% (+1.28%)
  • Historical Volatility 55.54%
  • IV Percentile 31%
  • IV Rank 28.08%
  • IV High 91.71% on 11/05/25
  • IV Low 34.94% on 03/19/25
  • Expected Move (DTE 26) 0.84 (10.39%)
  • Put/Call Vol Ratio 0.42
  • Today's Volume 10,495
  • Volume Avg (30-Day) 3,337
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 134,716
  • Open Int (30-Day) 128,884
  • Expected Range 7.26 to 8.94

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.73
  • Number of Estimates 1
  • High Estimate 0.73
  • Low Estimate 0.73
  • Prior Year 0.95
  • Growth Rate Est. (year over year) -23.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.50 +24.62%
on 02/12/26
9.94 -18.51%
on 01/23/26
-1.36 (-14.38%)
since 01/20/26
3-Month
6.50 +24.62%
on 02/12/26
9.94 -18.51%
on 01/23/26
+0.97 (+13.60%)
since 11/20/25
52-Week
6.18 +31.07%
on 10/30/25
16.18 -49.94%
on 02/25/25
-7.59 (-48.37%)
since 02/20/25

Most Recent Stories

More News
5 Revealing Analyst Questions From Organon’s Q4 Earnings Call

5 Revealing Analyst Questions From Organon’s Q4 Earnings Call

OGN : 8.10 (+7.71%)
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know

Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know

OGN : 8.10 (+7.71%)
AMPH : 28.53 (-0.04%)
NVAX : 9.20 (-0.27%)
OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook

OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook

OGN : 8.10 (+7.71%)
Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations

Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations

OGN : 8.10 (+7.71%)
Organon: Q4 Earnings Snapshot

Organon: Q4 Earnings Snapshot

OGN : 8.10 (+7.71%)
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025

Full year 2025 revenue of $6.2 billion, down 3% on both an as-reported basis and at constant currency Full year 2025 diluted earnings per share of $0.72 and non-GAAP Adjusted diluted...

OGN : 8.10 (+7.71%)
Organon Earnings: What To Look For From OGN

Organon Earnings: What To Look For From OGN

OGN : 8.10 (+7.71%)
2 Healthcare Stocks with Promising Prospects and 1 We Brush Off

2 Healthcare Stocks with Promising Prospects and 1 We Brush Off

OGN : 8.10 (+7.71%)
ALHC : 20.60 (-1.15%)
IRTC : 150.96 (-4.98%)
Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026

Organon (NYSE: OGN), a global healthcare company with a primary focus on women’s health, will release its fourth quarter and full year 2025 financial results on February 12, 2026, prior to the company’s...

OGN : 8.10 (+7.71%)
Organon Completes Divestiture of JADA® System to Laborie

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today the successful closing of the sale of its JADA ...

OGN : 8.10 (+7.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J.

See More

Key Turning Points

3rd Resistance Point 8.85
2nd Resistance Point 8.50
1st Resistance Point 8.30
Last Price 8.10
1st Support Level 7.75
2nd Support Level 7.40
3rd Support Level 7.20

See More

52-Week High 16.18
Fibonacci 61.8% 12.36
Fibonacci 50% 11.18
Fibonacci 38.2% 10.00
Last Price 8.10
52-Week Low 6.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar